APA (7th ed.) Citation

Minamiguchi, K., Irizato, M., Nakano, R., Kunichika, H., Tachiiri, T., Taiji, R., . . . Tanaka, T. (2025). Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Current Oncology, 32(12), 694. https://doi.org/10.3390/curroncol32120694

Chicago Style (17th ed.) Citation

Minamiguchi, Kiyoyuki, et al. "Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma." Current Oncology 32, no. 12 (2025): 694. https://doi.org/10.3390/curroncol32120694.

MLA (9th ed.) Citation

Minamiguchi, Kiyoyuki, et al. "Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma." Current Oncology, vol. 32, no. 12, 2025, p. 694, https://doi.org/10.3390/curroncol32120694.